IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease

OBJECTIVE: Systemic sclerosis (SSc) mortality is extremely variable in its internal organ involvement. Pulmonary fibrosis occurs in up to 30% of the cases. Animal models provide evidence that IL-33 is able to induce both cutaneous and pulmonary fibrosis via increased IL-13 and in SSc patients the le...

Descripción completa

Detalles Bibliográficos
Autores principales: Versace, Antonio Giovanni, Bitto, Alessandra, Ioppolo, Carmelo, Aragona, Caterina Oriana, La Rosa, Daniela, Roberts, William Neal, D'Angelo, Tommaso, Cinquegrani, Antonella, Cirmi, Santa, Irrera, Natasha, Navarra, Michele, Corrao, Salvatore, Gangemi, Sebastiano, Bagnato, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891529/
https://www.ncbi.nlm.nih.gov/pubmed/35252259
http://dx.doi.org/10.3389/fmed.2022.825567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891529/
https://www.ncbi.nlm.nih.gov/pubmed/35252259
http://dx.doi.org/10.3389/fmed.2022.825567

Ejemplares similares